Scholars Central

Review articlePublished 22 Jun 2015

IATROPHOBIC HYPERTENSION; WHITE COAT HYPERTENSION, WHAT?, WHY?, WHEN? â?? A REVIEW ARTICLE

Authors: M. Subrahmanyan, Satya Prasad Valluri

Journal of Evidence-Based Medicine and Healthcare

Volume 2 · Issue 6 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

White coat hypertension is defined by at least three separate clinic-based measurements. >140/90 mmHg and at least two non-clinic-based measurements. <140/90 mmHg in the absence of any evidence of target organ damage. As much as 20 percent of the population suffers from "white coat syndrome," in which blood pressure surges when measured in the doctor's office. The syndrome produces a challenge for physicians seeking an accurate blood pressure reading. At present, antihypertensive drug therapy is generally not recommended for patients with white coat hypertension, though it is reasonable to recommend appropriate lifestyle modifications aimed at reducing the blood pressure, as well as steps to reduce cardiac risk.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Evidence-Based Medicine and Healthcare
  • SubjectNursing & Healthcare
  • BylineArticles whose byline prints “M. Subrahmanyan”
  • BylineArticles whose byline prints “Satya Prasad Valluri”